EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

To Explore the Mechanism of Atorvastatin Pre-intervention on Cocl2-induced Cardiomyocytes

Zhuomin Wen, Limei Liang, Jiadong Liang, Zhuohua Zhang, Cunyu Pan, Weijie Zhou, Yuxin Jing, Guowu Lin

Research in Health Science · 2025

DOI: 10.22158/rhs.v10n2p20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Health Science, 2025. Verfasst von Zhuomin Wen und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atorvastatin calcium, known for its anti-inflammatory and atherosclerotic plaque-stabilizing effects, is widely used for the prevention and treatment of ischemic cardiovascular and cerebrovascular diseases, including coronary heart disease, angina pectoris, and cerebral infarction. Pyroptosis, a recently identified form of programmed cell death mediated by Caspase-1 and gasdermin D (GSDMD), is characterized by inflammasome activation and inflammatory cytokine release. Myocardial ischemia/reperfusion injury (MIRI) refers to exacerbated tissue damage that occurs when blood flow is restored (reperfusion) after a transient ischemic episode (insufficient blood supply). Pyroptosis has emerged as a central pathological mechanism in MIRI. In this study, we employed a rat MIRI model and an H9C2 cardiomyocyte hypoxia/reoxygenation (H/R) model to investigate the protective effects and underlying mechanisms of atorvastatin calcium pretreatment in both in vivo and in vitro systems.

Method

In vivo and in vitro models were established using ischemia/reperfusion (I/R) rats and cobalt chloride (CoCl₂)-induced hypoxia/reoxygenation (H/R) in H9C2 cells. Cell viability was measured via the CCK-8 assay. The expression levels of pyroptosis-related factors were assessed in both models through Western blotting, RT-qPCR, and immunohistochemical staining.

Result

Nucleotide-binding oligomerization domain (NOD)-like receptor signaling is an important pathway for mediating cardiac inflammation during myocardial I/R. In our experiments, Atorvastatin calcium pretreatment significantly ameliorates I/R-induced myocardial injury and H/R-induced pyroptosis, manifested by improved cardiac histopathology and cell viability. Western blot and RT-qPCR results showed that after pretreatment with atorvastatin calcium, atorvastatin calcium inhibited the expression of pro-inflammatory cytokines and pyro related molecules, including NLRP3, cleaved caspase-1, and GSDMD.

Conclusion

Our findings suggest that the NOD-like receptor signaling mediated inflammatory plays a pivotal role in myocardial I/R injury. After atorvastatin calcium pretreatment, inflammasome activation and pyroptosis are inhibited by the TLR4/Caspase-1/NLRP3 pathway, thus providing a potential strategy for the treatment of myocardial reperfusion injury.

Zitieren

APA

Wen, Z., Liang, L., Liang, J., Zhang, Z., Pan, C., Zhou, W., Jing, Y., & Lin, G. (2025). To Explore the Mechanism of Atorvastatin Pre-intervention on Cocl2-induced Cardiomyocytes. Research in Health Science. https://doi.org/10.22158/rhs.v10n2p20

Vancouver

Wen Z, Liang L, Liang J, Zhang Z, Pan C, Zhou W, et al. To Explore the Mechanism of Atorvastatin Pre-intervention on Cocl2-induced Cardiomyocytes. Research in Health Science. 2025. doi:10.22158/rhs.v10n2p20

BibTeX
@article{Wen2025,
  author = {Wen, Zhuomin and Liang, Limei and Liang, Jiadong and Zhang, Zhuohua and Pan, Cunyu and Zhou, Weijie and Jing, Yuxin and Lin, Guowu},
  title = {To Explore the Mechanism of Atorvastatin Pre-intervention on Cocl2-induced Cardiomyocytes},
  journal = {Research in Health Science},
  year = {2025},
  doi = {10.22158/rhs.v10n2p20}
}
Kostenlos starten →